Ajanta Pharma Limited’s promoter, Aayush Agrawal (Trustee Aayush Agrawal Trust), has announced the release of a pledge on 17,36,353 equity shares. This action, reported on September 16, 2026, is attributed to the repayment of a loan. This development signifies a positive shift in the promoter’s holding structure, potentially indicating strengthened financial health or reduced leverage.
Promoter Unpledges Significant Shareholding
In a significant disclosure, Aayush Agrawal, acting as the promoter and trustee of the Aayush Agrawal Trust, has formally announced the release of a pledge on a substantial block of 17,36,353 equity shares of Ajanta Pharma Limited. This announcement was made on September 16, 2026, and directly impacts the promoter’s shareholding and financial commitments.
Reason for Release: Loan Repayment
The primary reason cited for the release of this pledge is the full repayment of the loan that was secured against these shares. This action not only reduces the encumbrance on the promoter’s holdings but also suggests a healthier financial position for the promoter or a strategic decision to deleverage.
Disclosure Under SEBI Regulations
The disclosure has been made in compliance with the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, specifically under Regulation 31(1) and 31(2). The company’s scrip code for Ajanta Pharma Limited is BSE – AJANTPHARM 532331 and NSE – AJANTPHARM EQ. The enclosed forms provide detailed information regarding the release of the pledge on the shares.
Source: BSE
